Bananas against AIDS? (AEGiS) -
Bananas against AIDS?
afrol News - March 15, 2010
http://www.aegis.org/news/afrol/2010/AO100302.html

Scientists have found a special protein in the banana that could help women prevent being infected by HIV during sexual intercourse. They hope this may open the door to new and cheaper treatments to prevent the spread of AIDS.
The researchers, from the US University of Michigan Medical School, have an emerging interest in lectins, a type of proteins naturally occurring chemicals in plants, because of their ability to halt the chain of reaction that leads to a variety of infections.
"In laboratory tests, BanLec, the lectin found in bananas, was as potent as two current anti-HIV drugs," according to the study. Based on the findings published this month in the scientific 'Journal of Biological Chemistry,' "BanLec may become a less expensive new component of applied vaginal microbicides," researchers say.
Although condom use is quite effective, condoms are most successful in preventing infection if used consistently and correctly, which is often not the case.
"That is particularly true in developing countries where women have little control over sexual encounters so development of a long-lasting, self-applied microbicide is very attractive," says study senior author David Marvovitz.
Some of the most promising compounds for inhibiting vaginal and rectal HIV transmission are agents that block HIV prior to integration into its target cell, according to the study.
The new research describes the complex actions of lectins and their ability to outsmart HIV. Lectins are sugar-binding proteins. They can identify foreign invaders, like a virus, and attach themselves to the pathogen.
The researcher team discovered BanLec, the lectin in bananas, can inhibit HIV infection by binding to the sugar-rich HIV-1 envelope protein, gp120, and blocking its entry to the body.
"Therapies using BanLec could be cheaper to create than current anti-retroviral medications which use synthetically produced components, plus BanLec may provide a wider range of protection," the US researchers say.
"The problem with some HIV drugs is that the virus can mutate and become resistant, but that is much harder to do in the presence of lectins," says lead author Michael Swanson.
By staff writer
100315 AO100302

Copyright © 2010 - afrol News. All rights reserved. Reproducing or buying afrol News' articles. Reproduction of this article (other than one copy for personal reference) must be cleared through afrol News.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2010. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2010. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. [AEGiS]